Pub Date : 2026-01-01DOI: 10.2807/1560-7917.ES.2025.31.3.260122c
{"title":"Author's correction for Euro Surveill. 2026;31(3).","authors":"","doi":"10.2807/1560-7917.ES.2025.31.3.260122c","DOIUrl":"10.2807/1560-7917.ES.2025.31.3.260122c","url":null,"abstract":"","PeriodicalId":12161,"journal":{"name":"Eurosurveillance","volume":"31 3","pages":""},"PeriodicalIF":7.8,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12848988/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146028953","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-01DOI: 10.2807/1560-7917.ES.2026.31.2.2500974
Roberto Brunoro, Daniele Mengato, Francesco Barbaro, Lucrezia Calandrino, Anna Maria Cattelan, Francesca Venturini
{"title":"Letter to the editor: Addressing the blind spot of self-reported adherence in the era of long-acting PrEP.","authors":"Roberto Brunoro, Daniele Mengato, Francesco Barbaro, Lucrezia Calandrino, Anna Maria Cattelan, Francesca Venturini","doi":"10.2807/1560-7917.ES.2026.31.2.2500974","DOIUrl":"10.2807/1560-7917.ES.2026.31.2.2500974","url":null,"abstract":"","PeriodicalId":12161,"journal":{"name":"Eurosurveillance","volume":"31 2","pages":""},"PeriodicalIF":7.8,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12811703/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145988306","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-01DOI: 10.2807/1560-7917.ES.2026.31.2.2500965
Susanne Jacobsson, Michelle J Cole, Melissa Jansen van Rensburg, Daniel Schröder, Otilia Mårdh, Csaba Ködmön, Magnus Unemo
In 2024, based on the European Committee on Antimicrobial Susceptibility Testing breakpoint, we observed a tetracycline resistance prevalence of 62.3% (2,231/3,579) in Neisseria gonorrhoeae isolates from 22 European countries (range: 16.5-100%). Multivariable analysis of correlations between resistance and patients' epidemiological characteristics found tetracycline resistance associated with men who have sex with men (aOR: 1.38; 95% CI: 1.06-1.79). Our results are important when considering measures against transmission of sexually transmitted bacterial infections in Europe, such as in the context of doxycycline post-exposure prophylaxis (doxy-PEP).
{"title":"High prevalence of tetracycline resistance in <i>Neisseria gonorrhoeae</i> across 22 European countries, 2024.","authors":"Susanne Jacobsson, Michelle J Cole, Melissa Jansen van Rensburg, Daniel Schröder, Otilia Mårdh, Csaba Ködmön, Magnus Unemo","doi":"10.2807/1560-7917.ES.2026.31.2.2500965","DOIUrl":"10.2807/1560-7917.ES.2026.31.2.2500965","url":null,"abstract":"<p><p>In 2024, based on the European Committee on Antimicrobial Susceptibility Testing breakpoint, we observed a tetracycline resistance prevalence of 62.3% (2,231/3,579) in <i>Neisseria gonorrhoeae</i> isolates from 22 European countries (range: 16.5-100%). Multivariable analysis of correlations between resistance and patients' epidemiological characteristics found tetracycline resistance associated with men who have sex with men (aOR: 1.38; 95% CI: 1.06-1.79). Our results are important when considering measures against transmission of sexually transmitted bacterial infections in Europe, such as in the context of doxycycline post-exposure prophylaxis (doxy-PEP).</p>","PeriodicalId":12161,"journal":{"name":"Eurosurveillance","volume":"31 2","pages":""},"PeriodicalIF":7.8,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12811707/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145988023","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-01DOI: 10.2807/1560-7917.ES.2026.31.2.2600010
Davide Moschese, Andrea Antinori, Andrea Gori, Valentina Mazzotta
{"title":"Authors' response: Addressing the blind spot of self-reported adherence in the era of long-acting PrEP.","authors":"Davide Moschese, Andrea Antinori, Andrea Gori, Valentina Mazzotta","doi":"10.2807/1560-7917.ES.2026.31.2.2600010","DOIUrl":"10.2807/1560-7917.ES.2026.31.2.2600010","url":null,"abstract":"","PeriodicalId":12161,"journal":{"name":"Eurosurveillance","volume":"31 2","pages":""},"PeriodicalIF":7.8,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12811704/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145988925","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-01Epub Date: 2026-01-16DOI: 10.2807/1560-7917.ES.2020.31.3.260122ec
{"title":"Expression of concern for Euro Surveill. 2026;31(2).","authors":"","doi":"10.2807/1560-7917.ES.2020.31.3.260122ec","DOIUrl":"10.2807/1560-7917.ES.2020.31.3.260122ec","url":null,"abstract":"","PeriodicalId":12161,"journal":{"name":"Eurosurveillance","volume":" ","pages":""},"PeriodicalIF":7.8,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12848983/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145988971","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-01DOI: 10.2807/1560-7917.ES.2026.31.2.2500553
Richard Molenkamp, Lance D Presser, Sylvain Baize, Delphine Pannetier, Chantal Bem Reusken, Christian Drosten, Marion Koopmans
Currently, there is concern and uncertainty in the European and North American markets for in vitro diagnostics regarding the regulation of in vitro diagnostic tests. In the European Union, starting from May 2022, the regulation on vitro diagnostic medical devices (IVDR) has replaced the directive on in vitro diagnostic medical devices (IVDD). The IVDR, while written with the good intentions to ensure patient safety and health while supporting innovation and transparency, has resulted in uncertainty, instances of disruption of diagnostic development, and concerns related to pandemic preparedness and response. We here outline the history, current situation and concerns regarding pandemic preparedness in Europe. Finally, we make recommendations that could improve the IVDR while supporting pandemic preparedness.
{"title":"Despite good intentions, the regulation on in vitro diagnostic medical devices (IVDR) in Europe could impact negatively on preparedness and response for the next pandemic.","authors":"Richard Molenkamp, Lance D Presser, Sylvain Baize, Delphine Pannetier, Chantal Bem Reusken, Christian Drosten, Marion Koopmans","doi":"10.2807/1560-7917.ES.2026.31.2.2500553","DOIUrl":"10.2807/1560-7917.ES.2026.31.2.2500553","url":null,"abstract":"<p><p>Currently, there is concern and uncertainty in the European and North American markets for in vitro diagnostics regarding the regulation of in vitro diagnostic tests. In the European Union, starting from May 2022, the regulation on vitro diagnostic medical devices (IVDR) has replaced the directive on in vitro diagnostic medical devices (IVDD). The IVDR, while written with the good intentions to ensure patient safety and health while supporting innovation and transparency, has resulted in uncertainty, instances of disruption of diagnostic development, and concerns related to pandemic preparedness and response. We here outline the history, current situation and concerns regarding pandemic preparedness in Europe. Finally, we make recommendations that could improve the IVDR while supporting pandemic preparedness.</p>","PeriodicalId":12161,"journal":{"name":"Eurosurveillance","volume":"31 2","pages":""},"PeriodicalIF":7.8,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12811706/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145988939","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-12-01DOI: 10.2807/1560-7917.ES.2025.30.49.2500871
Roman Creuse, Alice Herteau, Anne Bernadou, Valérie Cesa, Karim Tararbit, Guillaume Lacour, Delphine Binet, Guillaume André Durand, Florian Franke, Catarina Krug, Laurent Filleul
In 2025, an unprecedented number of autochthonous chikungunya transmission events occurred in mainland France. One of the largest outbreaks took place in Bergerac (south-west France). By 27 October, 100 locally acquired cases were identified. They had symptom onsets between June and October. Our data suggest that door-knocking surveys and vector control measures assisted in slowing the virus spread. Autochthonous outbreaks of mosquito-borne diseases are expected to become more frequent with climate change, so improving outbreak control is crucial.
{"title":"Lessons from an investigation of an autochthonous chikungunya outbreak in Bergerac, mainland France, June to October 2025.","authors":"Roman Creuse, Alice Herteau, Anne Bernadou, Valérie Cesa, Karim Tararbit, Guillaume Lacour, Delphine Binet, Guillaume André Durand, Florian Franke, Catarina Krug, Laurent Filleul","doi":"10.2807/1560-7917.ES.2025.30.49.2500871","DOIUrl":"10.2807/1560-7917.ES.2025.30.49.2500871","url":null,"abstract":"<p><p>In 2025, an unprecedented number of autochthonous chikungunya transmission events occurred in mainland France. One of the largest outbreaks took place in Bergerac (south-west France). By 27 October, 100 locally acquired cases were identified. They had symptom onsets between June and October. Our data suggest that door-knocking surveys and vector control measures assisted in slowing the virus spread. Autochthonous outbreaks of mosquito-borne diseases are expected to become more frequent with climate change, so improving outbreak control is crucial.</p>","PeriodicalId":12161,"journal":{"name":"Eurosurveillance","volume":"30 49","pages":""},"PeriodicalIF":7.8,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12701331/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145741612","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-12-01DOI: 10.2807/1560-7917.ES.2025.30.49.2500892
Alexandra Czerniewska, Andrew Borman, Alireza Abdolrasouli, Emma L Budd, Matthew C Fisher, Richard Barton, Kieran A Bates, Jonathan Lambourne, Alicia Demirjian, Berit Muller-Pebody, Colin S Brown, Maria Saavedra-Campos, Rohini Manuel
Trichophyton indotineae is an emerging dermatophyte increasingly detected in the United Kingdom, often with antifungal resistance. We identified 363 cases between January 2017 and August 2025, with 310 cases (85%) since January 2023. Cases were mostly concentrated in major urban centres and most affected individuals were working-age adults, frequently reporting South Asian ethnicity. The importance of international importation vs domestic transmission remains unclear. Implementing enhanced surveillance would help to identify risk factors and transmission routes to focus prevention efforts.
{"title":"Rapid emergence of <i>Trichophyton indotineae</i> (<i>Trichophyton mentagrophytes</i> ITS genotype VIII) observed in the United Kingdom, up to August 2025.","authors":"Alexandra Czerniewska, Andrew Borman, Alireza Abdolrasouli, Emma L Budd, Matthew C Fisher, Richard Barton, Kieran A Bates, Jonathan Lambourne, Alicia Demirjian, Berit Muller-Pebody, Colin S Brown, Maria Saavedra-Campos, Rohini Manuel","doi":"10.2807/1560-7917.ES.2025.30.49.2500892","DOIUrl":"10.2807/1560-7917.ES.2025.30.49.2500892","url":null,"abstract":"<p><p><i>Trichophyton indotineae</i> is an emerging dermatophyte increasingly detected in the United Kingdom, often with antifungal resistance. We identified 363 cases between January 2017 and August 2025, with 310 cases (85%) since January 2023. Cases were mostly concentrated in major urban centres and most affected individuals were working-age adults, frequently reporting South Asian ethnicity. The importance of international importation vs domestic transmission remains unclear. Implementing enhanced surveillance would help to identify risk factors and transmission routes to focus prevention efforts.</p>","PeriodicalId":12161,"journal":{"name":"Eurosurveillance","volume":"30 49","pages":""},"PeriodicalIF":7.8,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12701335/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145741621","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-12-01DOI: 10.2807/1560-7917.ES.2025.30.49.2500364
Laura Kayaert, Carolina Jg Kampman, Helena Cm Driessen-Hulshof, Birgit Hb van Benthem
BACKGROUNDSyphilis is increasing among females and heterosexual males (heterosexuals) in Europe and other Western countries. In the Netherlands, there has been an increase in syphilis positivity and diagnoses over the last 10 years. Research on syphilis among heterosexuals and on spatiotemporal syphilis trends in the Netherlands is limited.AIMWe aimed to assess spatiotemporal trends and identify determinants of syphilis among heterosexuals in the Netherlands.METHODSThis study used national surveillance data of all sexual health centres (SHCs) and included consultations among heterosexuals tested for syphilis between 2011 and 2023. Syphilis was defined as an infectious syphilis diagnosis (primary, secondary or early latent). Spatiotemporal trends were assessed using SaTScan, adjusting for demographic and behavioural factors. We performed a multivariate logistic regression to identify demographic and behavioural determinants of syphilis.RESULTSWe analysed 694,698 STI consultations among heterosexuals and identified 686 syphilis diagnoses. We found an increase in syphilis positivity from 0.05% in 2011 to 0.23% in 2023. SaTScan identified two space-time clusters; one in the north (2020-23) and one in the south-west (2019-23) of the Netherlands. Living with HIV (adjusted odds ratio (aOR): 17.48; 95% CI: 11.75-25.08) and having symptoms (aOR: 2.73; 95% CI: 2.34-3.20) were most strongly associated with syphilis.CONCLUSIONWe found an increasing trend of syphilis among heterosexuals diagnosed at SHCs in the Netherlands. Syphilis was found in all regions. Since living with HIV was the strongest risk factor for syphilis, increased testing among heterosexuals living with HIV, both at SHCs and HIV treatment clinics, is recommended.
{"title":"Spatiotemporal trends and determinants of syphilis among heterosexual males and females in the Netherlands, 2011 to 2023.","authors":"Laura Kayaert, Carolina Jg Kampman, Helena Cm Driessen-Hulshof, Birgit Hb van Benthem","doi":"10.2807/1560-7917.ES.2025.30.49.2500364","DOIUrl":"10.2807/1560-7917.ES.2025.30.49.2500364","url":null,"abstract":"<p><p>BACKGROUNDSyphilis is increasing among females and heterosexual males (heterosexuals) in Europe and other Western countries. In the Netherlands, there has been an increase in syphilis positivity and diagnoses over the last 10 years. Research on syphilis among heterosexuals and on spatiotemporal syphilis trends in the Netherlands is limited.AIMWe aimed to assess spatiotemporal trends and identify determinants of syphilis among heterosexuals in the Netherlands.METHODSThis study used national surveillance data of all sexual health centres (SHCs) and included consultations among heterosexuals tested for syphilis between 2011 and 2023. Syphilis was defined as an infectious syphilis diagnosis (primary, secondary or early latent). Spatiotemporal trends were assessed using SaTScan, adjusting for demographic and behavioural factors. We performed a multivariate logistic regression to identify demographic and behavioural determinants of syphilis.RESULTSWe analysed 694,698 STI consultations among heterosexuals and identified 686 syphilis diagnoses. We found an increase in syphilis positivity from 0.05% in 2011 to 0.23% in 2023. SaTScan identified two space-time clusters; one in the north (2020-23) and one in the south-west (2019-23) of the Netherlands. Living with HIV (adjusted odds ratio (aOR): 17.48; 95% CI: 11.75-25.08) and having symptoms (aOR: 2.73; 95% CI: 2.34-3.20) were most strongly associated with syphilis.CONCLUSIONWe found an increasing trend of syphilis among heterosexuals diagnosed at SHCs in the Netherlands. Syphilis was found in all regions. Since living with HIV was the strongest risk factor for syphilis, increased testing among heterosexuals living with HIV, both at SHCs and HIV treatment clinics, is recommended.</p>","PeriodicalId":12161,"journal":{"name":"Eurosurveillance","volume":"30 49","pages":""},"PeriodicalIF":7.8,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12701334/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145741585","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Between July and October 2025, among the total 117 influenza A(H1N1)pdm09 strains characterised in Catalonia, 20% to 100% per week were carrying the NA:S247N substitution. The mutation, conferring reduced susceptibility to oseltamivir, was phenotypically confirmed (IC50 between 0.82 and 1.63 nM, compared to median IC50 of 0.3 nM for susceptible strains). An increased proportion of S247N variants was also observed in sequence data (10,944 sequences) from other parts of Spain and five of 35 submitting countries across Europe.
{"title":"Expansion of influenza A(H1N1)pdm09 NA:S247N viruses with reduced susceptibility to oseltamivir, Catalonia, Spain, and in Europe, July to October 2025.","authors":"Narcís Saubi, Cristina Andrés, Ignasi Prats-Méndez, Alejandra González-Sánchez, Alysa Davtyan, Rodrigo Vásquez-Mercado, Ariadna Rando, Patricia Nadal, Juliana Esperalba, Maria Arnedo, Marina Vicente, Eva Balada, Jacobo Mendioroz, María Carmen Martín, Karen García-Camuñas, Raquel Vaz, Adrià Najarro, Susana Bernalte, Nieves Larrosa, Andrés Antón","doi":"10.2807/1560-7917.ES.2025.30.48.2500873","DOIUrl":"10.2807/1560-7917.ES.2025.30.48.2500873","url":null,"abstract":"<p><p>Between July and October 2025, among the total 117 influenza A(H1N1)pdm09 strains characterised in Catalonia, 20% to 100% per week were carrying the NA:S247N substitution. The mutation, conferring reduced susceptibility to oseltamivir, was phenotypically confirmed (IC<sub>50</sub> between 0.82 and 1.63 nM, compared to median IC<sub>50</sub> of 0.3 nM for susceptible strains). An increased proportion of S247N variants was also observed in sequence data (10,944 sequences) from other parts of Spain and five of 35 submitting countries across Europe.</p>","PeriodicalId":12161,"journal":{"name":"Eurosurveillance","volume":"30 48","pages":""},"PeriodicalIF":7.8,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12680917/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145676875","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}